Capital International Investors Has $4.18 Billion Holdings in Danaher Corporation $DHR

Capital International Investors lifted its position in shares of Danaher Corporation (NYSE:DHR) by 8.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 18,246,008 shares of the conglomerate’s stock after buying an additional 1,487,768 shares during the quarter. Capital International Investors owned about 2.58% of Danaher worth $4,177,386,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of DHR. Elevated Capital Advisors LLC acquired a new stake in Danaher in the fourth quarter worth $26,000. JPL Wealth Management LLC acquired a new stake in Danaher in the third quarter worth $25,000. WFA of San Diego LLC acquired a new stake in Danaher in the second quarter worth $26,000. ANTIPODES PARTNERS Ltd acquired a new stake in Danaher in the third quarter worth $27,000. Finally, MidAtlantic Capital Management Inc. acquired a new stake in Danaher in the fourth quarter worth $33,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Down 1.2%

Shares of NYSE DHR opened at $184.45 on Friday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The company has a 50-day moving average price of $181.29 and a 200-day moving average price of $206.19. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The stock has a market capitalization of $130.55 billion, a P/E ratio of 35.68, a P/E/G ratio of 2.46 and a beta of 0.81.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm’s revenue was up 3.7% on a year-over-year basis. During the same period last year, the firm earned $1.88 earnings per share. On average, equities research analysts forecast that Danaher Corporation will post 8.43 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. Danaher’s payout ratio is 30.95%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on DHR shares. Morgan Stanley reduced their price target on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. DZ Bank started coverage on shares of Danaher in a report on Wednesday. They issued a “buy” rating and a $210.00 price target for the company. Robert W. Baird reduced their price target on shares of Danaher from $251.00 to $249.00 and set an “outperform” rating for the company in a report on Friday, April 17th. Evercore raised their price target on shares of Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a report on Tuesday, April 21st. Finally, Wolfe Research cut shares of Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average target price of $235.14.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.